Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juergen Wieland"'
Autor:
Juergen Wieland
Publikováno v:
2018 International Conference on Multidisciplinary Research. 2018:16-30
The objective of this study is to provide a better understanding of the challenges faced by software developers when developing safety-critical medical device software by the use of a plan-driven SDLC and to resolve these shortcomings by the proposit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3b563c77252544709b4caf1dde389fe
https://doi.org/10.26803/myres.2018.02
https://doi.org/10.26803/myres.2018.02
Publikováno v:
Drugs in R&D. 17:305-312
Ovaleap® (XM17) is a recombinant human follicle-stimulating hormone to treat infertility by inducing ovulation or controlled ovarian stimulation for assisted reproductive technology (ART) procedures. Ovaleap® (follitropin-α) was approved by the Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384025a56de349ad8816de812a7d9b5c
https://doi.org/10.1007/s40268-017-0182-z
https://doi.org/10.1007/s40268-017-0182-z
Publikováno v:
Drugs in R&D
Ovaleap® (XM17) is a recombinant human follicle-stimulating hormone to treat infertility by inducing ovulation or controlled ovarian stimulation for assisted reproductive technology (ART) procedures. Ovaleap® (follitropin-α) was approved by the Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfe8e049cec5681c6f8815173045d868
https://pubmed.ncbi.nlm.nih.gov/28386738
https://pubmed.ncbi.nlm.nih.gov/28386738